Surgalign Holdings is a global medical technology company focused on improving the standard of care by driving the evolution of digital health. Co. operates one reportable segment: Spine. Co. has a portfolio of spinal hardware implants, including solutions for fusion procedures in the lumbar, thoracic, and cervical spine, motion preservation solutions for the lumbar spine, and a minimally invasive surgical implant system for fusion of the sacroiliac joint. Co.'s spine implants portfolio includes spinal fusion devices. Co.'s portfolio of biomaterials includes products ranging from tissue-based solutions to synthetic bone graft substitutes for a range of surgical applications. We show 13 historical shares outstanding datapoints in our SRGA shares outstanding history coverage, used to compute SRGA market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing SRGA market cap history over the course of time is important for investors
interested in comparing SRGA's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of SRGA versus a peer is one thing; comparing
SRGA market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like SRGA can fluctuate over the course of history.
With this page we aim to empower investors researching SRGA by allowing them to research the SRGA market cap history. |
Free SRGA Email Alerts:
Video: The Importance of Market Cap
